Literature DB >> 27859969

FOXP1 enhances tumor cell migration by repression of NFAT1 transcriptional activity in MDA-MB-231 cells.

Sevil Oskay Halacli1.   

Abstract

Until now, forkhead box P1 (FOXP1) has been identified as a tumor suppressor in several correlation studies in breast cancer. Although FOXP1 is defined as a transcriptional repressor that interacts with other transcription factors in various mechanistic studies, there is no study that explains its repressor functions in breast cancer biology. This study demonstrated the repressor function of FOXP1 on nuclear factor of activated T cells (NFAT1) and the migratory effect of this repression in MDA-MB-231 breast cancer cells. Co-immunoprecipitation experiments were performed for the investigation of protein-protein interaction between two transcription factors. Protein-protein interaction on DNA was investigated with EMSA and transcriptional effects of FOXP1 on NFAT1, luciferase reporter assay was performed. Wound healing assay was used to analyze the effects of overexpression of FOXP1 on tumor cell migration. This study showed that FOXP1 has protein-protein interaction with NFAT1 on DNA and enhances breast cancer cell migration by repressing NFAT1 transcriptional activity and FOXP1 shows oncogenic function by regulating breast cancer cell motility.
© 2016 International Federation for Cell Biology.

Entities:  

Keywords:  FOXP1; NFAT; breast cancer; cell migration

Mesh:

Substances:

Year:  2016        PMID: 27859969     DOI: 10.1002/cbin.10702

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  9 in total

1.  PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression.

Authors:  Kelly Chiang; Agnieszka E Zielinska; Abeer M Shaaban; Maria Pilar Sanchez-Bailon; James Jarrold; Thomas L Clarke; Jingxian Zhang; Adele Francis; Louise J Jones; Sally Smith; Olena Barbash; Ernesto Guccione; Gillian Farnie; Matthew J Smalley; Clare C Davies
Journal:  Cell Rep       Date:  2017-12-19       Impact factor: 9.423

2.  Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer.

Authors:  Bao-Hua Yu; Bai-Zhou Li; Xiao-Yan Zhou; Da-Ren Shi; Wen-Tao Yang
Journal:  Diagn Pathol       Date:  2018-05-30       Impact factor: 2.644

3.  A dual role of miR-22 modulated by RelA/p65 in resensitizing fulvestrant-resistant breast cancer cells to fulvestrant by targeting FOXP1 and HDAC4 and constitutive acetylation of p53 at Lys382.

Authors:  Bo Wang; Dongping Li; Jody Filkowski; Rocio Rodriguez-Juarez; Quinn Storozynsky; Megan Malach; Emily Carpenter; Olga Kovalchuk
Journal:  Oncogenesis       Date:  2018-07-30       Impact factor: 7.485

4.  CASC21, a FOXP1 induced long non-coding RNA, promotes colorectal cancer growth by regulating CDK6.

Authors:  Tao Gong; Yu Li; Liang Feng; MingZhi Fang; Guoliang Dai; Xin Huang; Ye Yang; Shenlin Liu
Journal:  Aging (Albany NY)       Date:  2020-06-25       Impact factor: 5.682

5.  Upregulation of FOXP4 in breast cancer promotes migration and invasion through facilitating EMT.

Authors:  Tao Ma; Jin Zhang
Journal:  Cancer Manag Res       Date:  2019-04-08       Impact factor: 3.989

6.  Long non-coding RNA HCG11 modulates glioma progression through cooperating with miR-496/CPEB3 axis.

Authors:  Yangzong Chen; Chunchun Bao; Xiuxing Zhang; Xinshi Lin; Hongou Huang; Zhiqiang Wang
Journal:  Cell Prolif       Date:  2019-07-16       Impact factor: 6.831

Review 7.  Molecular networks of FOXP family: dual biologic functions, interplay with other molecules and clinical implications in cancer progression.

Authors:  Ju-Ha Kim; Jisung Hwang; Ji Hoon Jung; Hyo-Jung Lee; Dae Young Lee; Sung-Hoon Kim
Journal:  Mol Cancer       Date:  2019-12-09       Impact factor: 27.401

8.  PGRMC1 Inhibits Progesterone-Evoked Proliferation and Ca2+ Entry Via STIM2 in MDA-MB-231 Cells.

Authors:  Carlos Cantonero; Ginés M Salido; Juan A Rosado; Pedro C Redondo
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

9.  Low expression of FOXP2 predicts poor survival and targets caspase-1 to inhibit cell pyroptosis in colorectal cancer.

Authors:  Peng Liao; Wu-Hua Huang; Li Cao; Tao Wang; Li-Ming Chen
Journal:  J Cancer       Date:  2022-01-16       Impact factor: 4.207

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.